Home

Newsroom

2007

Main contents starts here

News and Press Releases 2007

November 6, 2007
“Move to AMITIZA” Advertising Campaign Underscores the Power of Not Letting Chronic Constipation Slow People Down
October 24, 2007
Student Scientists Receive Scholarships to Advance Research
September 11, 2007
Takeda Statement on ACTOS® (pioglitazone HCl) Meta-Analysis Published in the Journal of the American Medical Association
July 30, 2007
Takeda Responds to the FDA Advisory Committee Recommendation
July 12, 2007
Sucampo Pharmaceuticals Submits Supplemental New Drug Application for Lubiprostone to Treat Irritable Bowel Syndrome with Constipation
June 19, 2007
U.S. Green Building Council Awards Takeda U.S. Home Office LEED Gold Environmental Certification
June 6, 2007
Takeda Revises ACTOS® (pioglitazone HCl) Prescribing Label
May 22, 2007
New Study Suggests No Significant Impairment in Middle-of-the-Night Balance, Mobility or Memory in Older Adults Using Ramelteon
May 21, 2007
New Study Demonstrates that Lubiprostone May Improve Symptom Relief Rates in Adults with Irritable Bowel Syndrome with Constipation (IBS-C)
May 14, 2007
Takeda Expands Support of Community Health and Wellness Initiatives in Partnership with Two Local Not-for-Profit Organizations
February 26, 2007
Takeda and TAP to Promote Sucampo's AMITIZA® in the United States
January 19, 2007
Takeda Global Research & Development Center, Inc. Names Dr. Mehmood Khan President
January 8, 2007
Takeda Pharmaceuticals North America Names Vice President of Human Resources and Administration